cell therapies is an Australian-based, globally-active commercial contract development and manufacturing company, specializing in cell therapy, gene therapy, regenerative medicine, and cellular immunotherapy products.
A leader in this groundbreaking field, our expert team and world-class facilities have been developing and manufacturing cutting edge treatments for cancer and rare diseases on behalf of local and international clients since 2003.
Cell Therapies has extensive experience in the development and commercialization of cell and gene therapies for the Australian and global markets.
Over 18 years’ experience managing apheresis collections under GMP quality oversight
Licensed GMP manufacturing and process development for clinical trials and commercial supply
Enabling global clinical trial establishment by assisting from trial design to regulatory submission
The expertise to advance your program from clinical trial through to commercial supply
cell therapies ’ GMP facility is located in Melbourne, Australia, and has manufacturing licences for clinical and commercial supply from Australia’s regulatory agency, the Therapeutic Goods Administration (TGA). Our facility also complies with global regulatory standards for US (FDA), Europe (EMA), Japan (MHLW) and other jurisdictions.
Reach out to our expert team by entering your details below and we will get into contact with you.
